Stem cell based small molecule therapy for Alzheimer’s disease
Over 6 million people in the US suffer from AD. There are no drugs that prevent the death of nerve cells in AD, nor has any drug been identified that…
Over 6 million people in the US suffer from AD. There are no drugs that prevent the death of nerve cells in AD, nor has any drug been identified that…
We propose to discover new drug candidates for Alzheimer’s Disease (AD), which is common, fatal, and for which no effective disease-modifying drugs are available. Because no effective AD treatment is…
Alzheimer’s disease (AD) is an incurable disorder that affects memory, social interaction and the ability to perform everyday activities. In the USA alone, the number of AD patients aged 65…
Alzheimer’s disease (AD) is now a nation-wide epidemic and California is at the epicenter of the epidemic. One-tenth of all people in the United States diagnosed with AD live in…
By 25, Lauren Miller had already lost two grandparents to Alzheimer's and witnessed her mother's early onset at just 55 years old. Watch Lauren's recent talk about her family history…
In this first installment of CIRM TV's "Ask the Expert" video series, Larry Goldstein of the University of California, San Diego answers questions about finding stem cell based therapies for…
Bonus footage from the first installment of CIRM TV's "Ask the Expert" video series in which Larry Goldstein of the University of California, San Diego answers questions about finding stem…
Mathew Blurton-Jones speaks at the 2011 CIRM Grantee Meeting about promising research which uses neural stem cells to improve learning and memory in mice with alzheimer's like symptoms.